ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,436.44
      -0.50%
      US Tech 100
      18,604.00
      1.65%
      Dow Jones
      40,743.33
      0.00%
      Brent Oil
      80.355
      2.28%
      Bitcoin
      66,029.35
      -0.21%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Reviva Pharmaceuticals Holdings Inc (RVPH)

      7. Reviva Pharmaceuticals Holdings Inc (RVPH) Financials

      Reviva Pharmaceuticals Holdings Inc

      Reviva Pharmaceuticals Holdings Inc (RVPH)

      NASDAQ
      1.11
      -0.04
      (-3.48%)
      Closed July 30 4:00PM
      Delayed by 15 minutes
      1.11
      0.00
      ( 0.00% )
      Pre Market: 7:07AM
      Delayed by 15 minutes

      Reviva Pharmaceuticals Holdings Inc Financial Summary

      The current RVPH market cap is 30.99M. The company's latest EPS is USD -1.4063 and P/E is -6.22.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -6.74M-12.07M-10.71M-9.99M-7.92M
      Net Income -6.6M-12.44M-10.49M-9.73M-7.43M
      Year End December 30 2023 20202020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -725k-2.43M-10.11M-24.31M-39.5M
      Net Income 618k-3.78M-8.52M-24.34M-39.26M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 12.9M11.84M5.39M23.7M13.5M
      Total Liabilities 7.12M10.22M13.91M17.98M14.84M
      Total Equity 5.79M1.62M-8.52M5.72M-1.35M
      Year End December 30 2023 20202020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 61.02M8.76M31.4M18.92M23.7M
      Total Liabilities 3.26M1.33M2.72M6.61M17.98M
      Total Equity 5M7.43M28.69M12.32M5.72M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -7.95M-13.27M-19.45M-28.33M-11.73M
      Investing N/A N/A N/A N/A N/A
      Financing 687k5.9M5.9M33.17M332k
      Year End December 30 2023 20202020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -427k-3.73M-10.67M-18.96M-28.33M
      Investing 5.7M N/A N/A N/A N/A
      Financing -5.52M12.49M31.6M7.79M33.17M

      Stats and Ratios

      Market Cap 30.99M
      Price to Earnings Ratio -6.22
      Price to Sales Ratio 0
      Price to Cash Ratio 10.45
      Price to Book Ratio 42.72
      Dividend Yield -

      Share Statistics

      Shares Outstanding 27.92M
      Average Volume (1 week) 289.57k
      Average Volume (1 Month) 320.68k
      52 Week Change -75.76%
      52 Week High 6.80
      52 Week Low 0.95
      Spread (Intraday) 0.08 (6.78%)

      Company Info

      Company Name Reviva Pharmaceuticals Holdings Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://revivapharma.com
      Industry pharmaceutical preparations (2834)